2010 financials
Teva reports strong Q1 results
May 10, 2010Sales and Marketing 2010 financials, Teva
Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …
Lundbeck delivers strong results and builds on pipeline
May 7, 20102010 financials, Azilect, Lundbeck
Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …
Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Novartis shines in first quarter
April 21, 2010Sales and Marketing 2010 financials, Alcon, Novartis
Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …
Lilly faces substantial costs from US health reform
April 20, 2010Sales and Marketing 2010 financials, Obama, lilly
Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …
